Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
Green Tech Surge Data Centers Worldwide Go Carbon Neutral, Indian Giants Join Sustainability Push
Stevens Point, Wisconsin, tests upgraded storm sirens as part of emergency system maintenance
MetService warns NZ of 120 km/h gusts, floods and landslides amid cold‑front storm
China offers to mediate Thailand Cambodia border dispute through friendly dialogue
Haryana-Jhajjar 4.4 quake triggers school safety drills in Delhi‑NCR
